Back to Search Start Over

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

Authors :
Durant, J
Clevenbergh, P
Halfon, P
Delgiudice, P
Porsin, S
Simonet, P
Montagne, N
Boucher, CAB
Schapiro, JM
Dellamonica, P
Source :
The Lancet; June 1999, Vol. 353 Issue: 9171 p2195-2199, 5p
Publication Year :
1999

Abstract

Growing evidence has linked HIV-1 resistance mutations and drug failure. The use of genotypic-resistance analysis to assist therapeutic decision-making in patients failing therapy has not been investigated. We assessed the virological and immunological impact of genotypic-resistance testing.

Details

Language :
English
ISSN :
01406736 and 1474547X
Volume :
353
Issue :
9171
Database :
Supplemental Index
Journal :
The Lancet
Publication Type :
Periodical
Accession number :
ejs6993958
Full Text :
https://doi.org/10.1016/S0140-6736(98)12291-2